Back to Search Start Over

Attention-deficit/hyperactivity disorder.

Authors :
Faraone SV
Bellgrove MA
Brikell I
Cortese S
Hartman CA
Hollis C
Newcorn JH
Philipsen A
Polanczyk GV
Rubia K
Sibley MH
Buitelaar JK
Source :
Nature reviews. Disease primers [Nat Rev Dis Primers] 2024 Feb 22; Vol. 10 (1), pp. 11. Date of Electronic Publication: 2024 Feb 22.
Publication Year :
2024

Abstract

Attention-deficit/hyperactivity disorder (ADHD; also known as hyperkinetic disorder) is a common neurodevelopmental condition that affects children and adults worldwide. ADHD has a predominantly genetic aetiology that involves common and rare genetic variants. Some environmental correlates of the disorder have been discovered but causation has been difficult to establish. The heterogeneity of the condition is evident in the diverse presentation of symptoms and levels of impairment, the numerous co-occurring mental and physical conditions, the various domains of neurocognitive impairment, and extensive minor structural and functional brain differences. The diagnosis of ADHD is reliable and valid when evaluated with standard diagnostic criteria. Curative treatments for ADHD do not exist but evidence-based treatments substantially reduce symptoms and/or functional impairment. Medications are effective for core symptoms and are usually well tolerated. Some non-pharmacological treatments are valuable, especially for improving adaptive functioning. Clinical and neurobiological research is ongoing and could lead to the creation of personalized diagnostic and therapeutic approaches for this disorder.<br /> (© 2024. Springer Nature Limited.)

Details

Language :
English
ISSN :
2056-676X
Volume :
10
Issue :
1
Database :
MEDLINE
Journal :
Nature reviews. Disease primers
Publication Type :
Academic Journal
Accession number :
38388701
Full Text :
https://doi.org/10.1038/s41572-024-00495-0